CYLINDER, GRADUATED, LABORATORY

The Defense Logistics Agency awarded Contract SPE2DS26V8051 to PACIFIC STAR CORPORATION (CAGE 4QNY3) on July 23, 2026, for the procurement of two graduated laboratory cylinders, each 100 mL, under NSN 6640004200000, with a total contract value of $60.16. The solicitation, SPE2DS-26-T-248H, was issued under a simplified acquisition procedure and directed delivery to the USS NEW YORK LPD21 under FOB Destination terms, with a required delivery date of July 21, 2026, and flexibility for delivery within 20 days as directed by order. The contract incorporates a comprehensive suite of Federal Acquisition Regulation (FAR) and Defense Federal Acquisition Regulation Supplement (DFARS) clauses, including mandatory compliance with sustainable products requirements, employment eligibility verification, combating human trafficking, hazardous materials identification, cybersecurity safeguards including NIST SP 800-171 and safeguarding covered defense information, and restrictions on covered telecommunications equipment. Packaging and labeling must adhere strictly to MIL-STD-129 and DLA's RP001 packaging standards, with commercial packaging governed by ASTM D3951 unless superseded by DLA requirements, and hazardous materials subject to TQ IP025 and DFARS 252.223-7001 labeling standards. Invoicing and payment processing are required via WAWF, with accelerated payments to small business subcontractors enabled under clause 52.232-40. The contractor must comply with representations regarding entity identification, socioeconomic status, and prohibitions on forced arbitration, whistleblower retaliation, and unauthorized personnel compensation. The contract includes clauses for inspection and acceptance at the destination, contract changes under fixed-price terms, and unenforceability of unauthorized obligations. Although no detailed statement of work or evaluation factors were provided, the award reflects a streamlined acquisition process with strict regulatory, security, and logistical controls typical of DLA medical supply chain contracts.